Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.
Ascentage Pharma Group International - Unsponsored ADR (AAPG) Earnings per Share (EPS) (Diluted) data is not available.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Earnings per Share (EPS) (Diluted) |
-- |
| Balance Sheet Financials | |
$266.45M |
|
$114.64M |
|
$158.78M |
|
$425.23M |
|
$173.00M |
|
$123.18M |
|
$157.87M |
|
$330.87M |
|
$94.35M |
|
$81.00M |
|
$94.35M |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|